UroGen Pharma (URGN) Share-based Compensation (2017 - 2026)
UroGen Pharma (URGN) recorded Share-based Compensation of $5.33 million in Q2 2026, up 95.1% from $2.73 million a year earlier and up 15.2% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Share-based Compensation (2017 - 2026) Analysis & Trends
On a TTM basis, UroGen Pharma's Share-based Compensation came in at $16.12 million as of Jun 30, 2026, up 28.0% year-over-year; for FY2025, it came in at $11.96 million, down 8.8% from FY2024.
- Annual Share-based Compensation has a five-year compound annual growth rate of -15.7% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $13.11 million in FY2024 (+40.3%), $9.34 million in FY2023 (-11.7%), $10.58 million in FY2022 (-54.2%) and $23.11 million in FY2021 (-17.5%).
- The Q2 2026 figure is the highest quarterly Share-based Compensation since Q4 2021.
- On a year-over-year basis, Share-based Compensation rose in five of the last eight quarters, with growth averaging 24.9%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 95.1% in Q2 2026, against a decline of 55.8% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.63 million (Q1 2026), $3.13 million (Q4 2025) and $3.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | UroGen Pharma | 1.98 Bn | 1.48 Bn | 65.88 Mn | 5.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.33 Mn |
| Mar 31, 2026 | 4.63 Mn |
| Dec 31, 2025 | 3.13 Mn |
| Sep 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 3.07 Mn |
| Dec 31, 2024 | 3.30 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 3.56 Mn |
| Mar 31, 2024 | 2.76 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 2.22 Mn |
| Mar 31, 2023 | 2.29 Mn |
| Dec 31, 2022 | 2.37 Mn |
| Sep 30, 2022 | 2.44 Mn |
| Jun 30, 2022 | 2.82 Mn |
| Mar 31, 2022 | 2.95 Mn |
| Dec 31, 2021 | 5.36 Mn |
| Sep 30, 2021 | 5.52 Mn |
API Access
UroGen Pharma Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();